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ABSTRACT
In the Women’s Health Initiative (WHI), we investigated associations between baseline dual-energy X-ray absorptiometry (DXA)
appendicular lean mass (ALM) and risk of incident fractures, falls, and mortality (separately for each outcome) among older postmen-
opausal women, accounting for bone mineral density (BMD), prior falls, and Fracture Risk Assessment Tool (FRAX®) probability. The
WHI is a prospective study of postmenopausal women undertaken at 40 US sites. We used an extension of Poisson regression to
investigate the relationship between baseline ALM (corrected for height2) and incident fracture outcomes, presented here for major
osteoporotic fracture (MOF: hip, clinical vertebral, forearm, or proximal humerus), falls, and death. Associations were adjusted for age,
time since baseline and randomization group, or additionally for femoral neck (FN) BMD, prior falls, or FRAX probability (MOF without
BMD) and are reported as gradient of risk (GR: hazard ratio for first incident fracture per SD increment) in ALM/height2 (GR). Data were
available for 11,187 women (mean [SD] age 63.3 [7.4] years). In the base models (adjusted for age, follow-up time, and randomization
group), greater ALM/height2 was associated with lower risk of incident MOF (GR = 0.88; 95% confidence interval [CI] 0.83–0.94). The
association was independent of prior falls but was attenuated by FRAX probability. Adjustment for FN BMD T-score led to attenuation
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and inversion of the risk relationship (GR = 1.06; 95% CI 0.98–1.14). There were no associations between ALM/height2 and incident
falls. However, there was a 7% to 15% increase in risk of death during follow-up for each SD greater ALM/height2, depending on spe-
cific adjustment. In WHI, and consistent with our findings in older men (Osteoporotic Fractures in Men [MrOS] study cohorts), the pre-
dictive value of DXA-ALM for future clinical fracture is attenuated (and potentially inverted) after adjustment for femoral neck BMD T-
score. However, intriguing positive, but modest, associations between ALM/height2 andmortality remain robust. © 2021 The Authors.
Journal of Bone andMineral Research published byWiley Periodicals LLC on behalf of American Society for Bone andMineral Research
(ASBMR).
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Introduction
D ual-energy X-ray absorptiometry (DXA)–derived appendicularlean mass (ALM) is central to the more than 10 current opera-
tional definitions of sarcopenia.(1,2) Concerns over the predictive
value of DXA ALM for incident health outcomes such as fractures,
falls, and death have led to more recent sarcopenia definitions
incorporating measures of physical performance/function and
muscle strength, rather than being based solely on ALM.(1,2) Indeed,
the most recent European working group consensus definition
focuses principally on physical function as the initial criterion for
sarcopenia definition(3) and the 2020 US Sarcopenia Definitions
and Outcomes Consortium approach dispenses with ALM
entirely.(4,5) There is evidence that DXA ALM is variably predictive
of fracture outcomes in men, particularly when femoral neck bone
mineral density (BMD) is also included in the analyses.(1) For exam-
ple, we have demonstrated recently in the US, Sweden, and Hong
Kong Osteoporotic Fractures in Men (MrOS) study cohorts that
DXA ALM, both as a crude measure and normalized for height, is
only modestly predictive of incident fractures; when femoral neck
(FN) BMD T-score is also considered, the predictive value is attenu-
ated to the null, or even, in the case of hip fracture, inverted, such
that greater DXA ALM becomes a risk factor for fracture.(6) Similar
findings have emerged from the US Health ABC cohort,(7)with sup-
portive evidence in women fromWomen’s Health Initiative (WHI)(8)
and Framingham,(9) but whether these considerations apply to the
related outcomes of incident falls andmortality is unclear. Addition-
ally, the independent value of ALM in predicting fracture outcomes,
after controlling for falls, Fracture Risk Assessment Tool (FRAX®)
probability, or femoral neck BMD has to date not been quantified
in women. Given that the acquisition of DXA ALM requires an addi-
tional scan, which may take between 5 and 15 minutes depending
on the instrument and the size of the participant, if it does not add
useful risk information for a particular outcome over and above
more easily obtainable measures, such as femoral neck BMD (for
which the scanning time is usually less than 30 seconds), FRAX
probability, or history of falls, then its value as part of sarcopenia
definitions is questionable, at least in the context of that outcome.(1)
Building on our previous findings in men, the aim of the present
study was to examine, in a large population of older women, first
whether DXA ALM is predictive of incident fractures independent
of currentmeasures such as femoral neck BMD, prior falls, and FRAX
probability, and second to elucidate associations between baseline
DXA ALM and incident falls and mortality.
Materials and Methods
Participants
TheWHI is a prospective health study in the United States under-
taken at 40 centers and focused on strategies for preventing
heart disease, breast and colorectal cancer, and osteoporotic
fractures in postmenopausal women. The WHI included
161,808 women aged 50 to 79 years at baseline, who were post-
menopausal and with predicted survival of 3 or more years. The
WHI structure and methods have been presented in detail previ-
ously.(8,10,11) In brief, women were enrolled at 40 US clinical cen-
ters into one or more randomized clinical trials (low-fat diets
[DM], hormone therapy [HT], or calcium and vitamin D [CAD]
supplementation). Women who were ineligible or not interested
in participating in the clinical trials were enrolled in the observa-
tional study (OS). In this analysis, we studied the cohort of
women who had undergone DXA assessment at baseline, at
one of three centers, spanning participants from DM, HT, CAD,
and OS studies, described below. The analysis dataset comprised
all individuals from the four WHI studies for whom required
exposure and outcome data were available. No other inclusion/
exclusion criteria were applied.
Exposure variables
At baseline, height, using a wall-mounted stadiometer (to the
nearest 0.1 cm), and weight, using a balance beam scale (to the
nearest 0.1 kg), were measured, and body mass index (BMI)
was calculated as kg/m2. Hip and waist circumferences were
measured to the nearest 0.5 cm, the latter at the level of the
umbilicus over nonbinding undergarments. The WHI question-
naire was administered at baseline to collect information about
current smoking, number and type of medications, fracture his-
tory, family history of hip fracture, past medical history (rheuma-
toid arthritis), and high consumption of alcohol (three or more
glasses of alcohol-containing drinks per day). Previous fracture
at baseline was documented as all fractures occurring after the
age of 55 years. Glucocorticoid exposure was recorded as use
at least three times per week in the month preceding the base-
line assessment. Given their rarity in this cohort, apart from glu-
cocorticoid use and rheumatoid arthritis (both FRAX input
variables), we did not consider secondary causes of osteoporosis
and the “secondary osteoporosis” input variable for FRAX prob-
ability calculation was set to no for all women.(6) The number of
falls during the 12 months preceding the baseline visit was
recorded by self-assessment questionnaire (past falls). In the
WHI Bone Density Study, BMD and body composition, including
ALM, were measured at three US clinic sites (Pittsburgh, PA; Bir-
mingham, AL; Phoenix/Tucson, AZ), using Hologic QDR 2000,
2000+ or 4500 instruments (Hologic, Bedford, MA, USA), in par-
ticipants of all three component trials and the observational
study. A standardized procedure for participant positioning
and scan analysis was used at all centers. Phantom scans, scans
with specific problems, and a random sampling of scans were
reviewed in the WHI quality assurance program to monitor
machine and technician, and cross-calibration was
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undertaken.(8,10,11) The DXA assessment also generated total
body fat mass (kg). In the analysis cohort, 10-year probability of
fracture (FRAXmajor osteoporotic fracture [hip, humerus, clinical
vertebral, or forearm]) was calculated using clinical risk factors
described above with and without femoral neck BMD entered
into the US-specific FRAX model.
Fracture, fall, and death outcomes
Fractures were initially reported by participants and subse-
quently verified by radiology review or operative reports by cen-
trally trained and blinded physician adjudicators at each clinical
center.(11,12) Final adjudication of hip fractures was performed
centrally by blinded adjudicators. Incident falls were assessed
by questionnaire at follow-up (at least annually), using the ques-
tion, “Since your last medical update, how many times did you
fall and land on the floor or ground?” (with options ranging from
0 to 3 or more). Deaths were ascertained from registry data and
reports from family members/physicians.
Statistical methods
Clinical outcomes comprised: any fracture, osteoporotic fracture
(OF: defined consistent with Kanis et al. 2001(13) as clinical verte-
bral, pelvis, humerus, sacrum/coccyx, scapula, sternum, hip,
other femoral fractures, tibia, fibula, distal forearm), major osteo-
porotic fracture (MOF: hip, clinical vertebral, humerus or forearm)
and hip fracture, incident falls, and death. An extension of Pois-
son regression models(14) was used to study the association
between the ALM/height2, FRAX, prior falls, BMD, and the risk
of incident outcomes. ALM/height2 was first standardized
(in the whole analysis cohort) to a normally distributed variable
with mean 0.00 and SD 1.00. All associations were adjusted for
current age, current time since baseline, randomization (to low-
fat diet, hormone therapy, calcium and vitamin D supplementa-
tion, or placebo), and participation in the observational study. In
contrast to logistic regression, the Poisson regression uses the
length of each individual’s follow-up period and the hazard func-
tion is assumed to be exp(β0 + β1  current time from baseline +
β2  current age + β3  variable of interest). The observation
period of each participant was divided into intervals of 1 month.
One fracture per person and time to the first fracture were
counted, and time at risk was censored at the time of first frac-
ture, loss to follow-up, death, or end of follow-up. Unlike a Cox
model, the Poisson model uses a data duplication method,
accounting for the competing mortality risk for fracture risk
prediction.(15)
We initially investigated the predictive value of ALM/height2
adjusted only for current age and follow-up time. Subsequently,
we used multivariate models to investigate the predictive value
of ALM/height2 independent of FRAX, prior falls, or BMD. Interac-
tions between ALM/height2 and current age and between ALM/-
height2 and current time since baseline were also investigated in
order to elucidate whether the associations between ALM/-
height2 and outcomes differed by age or time since baseline.
DXA total fat mass and waist/hip ratio were used in post hoc
exploratory models with mortality as the outcome. These explor-
atory analyses were undertaken to further investigate emergent
findings and therefore were not documented in the original
analysis plan.
The associations between ALM and outcomes are presented as
a gradient of risk (GR = hazard ratio per SD) together with 95%
confidence intervals (CI). Two-sided p values were used for all ana-
lyses and p < .05 was considered to be statistically significant.
Results
Characteristics of the participants
We studied 11,187 women (Table 1). Their mean age was
63.3 years (SD 7.4 years) and 17% had experienced a prior frac-
ture since the age of 55 years. In the preceding 12 months,
33% had experienced a fall. Average follow-up time was
14.1 years, with a maximum of 21.5 years. Supplemental
Table SS1 documents the baseline characteristics by quarter of
ALM/height2.
Associations between DXA ALM and incident fracture
Associations between ALM/height2 and risk of incident fractures
are presented in Table 2. Greater ALM/height2was associatedwith
lower risk of incident fracture, whether this was categorized as any
clinical fracture, osteoporotic fracture, MOF, or hip fracture. The
hazard ratio per standard deviation increase (GR) was similar for
all fracture types with the greatest magnitude of association for
hip fracture (GR = 0.81 [95% CI 0.71–0.91]), and weakest associa-
tion for any clinical fracture (GR = 0.91 [95% CI 0.87–0.96]).
Fracture outcomes and adjustment for prior falls, FRAX
probability, or femoral neck BMD T-score
Associations between ALM/height2 and incident fracture were
not materially changed by inclusion of prior falls in the regres-
sion models (Table 2). Adjustment for FRAX probability of major
osteoporotic fracture calculated with or without femoral neck
BMD attenuated the associations to close to unity except for
hip fracture (GR = 0.88 [95% CI 0.78–1.00] and GR = 0.86 [95%
CI 0.76–0.98]) for FRAX with and without BMD, respectively).
Adjustment for femoral neck BMD T-score led to the point esti-
mates for the GR becoming greater than unity, which were statis-
tically significant for all fracture outcomes other than hip
fracture. Fig. 1 documents these associations for the outcomes
of osteoporotic fracture and major osteoporotic fracture.
Associations between DXA ALM and incident falls
The relationships between ALM/height2 and incident falls are
summarized in Table 3. There were no statistically significant
associations.
Associations between DXA ALM and incident mortality
In contrast, for each standard deviation greater ALM/height2, the
risk of death during follow-up was 13% higher (GR = 1.13 [95% CI
1.08–1.18]; Table 3). This was not materially changed by adjust-
ment for either prior falls, FRAX, or femoral neck BMD. We inves-
tigated whether this positive association between ALM/height2
and deathmight be explained by DXA total fat mass ormeasured
waist/hip ratio, but additional adjustment (with age and follow-
up time) for these variables did not materially alter the relation-
ship (total fat mass: GR = 1.10 [95% CI 1.05–1.16); waist/hip ratio
GR = 1.07 [95% CI 1.02–1,12]). Furthermore, findings were consis-
tent with ALM rather than ALM/height2 as the exposure.
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Interactions with age and follow-up time
We observed no evidence that the relationship between DXA
ALM/height2 and outcomes varied by age except for hip fracture,
where the GR rose modestly with increasing age (p-interac-
tion= 0.15), and formortality, where the effect size decreasedwith
greater age (p-interaction = 0.035). These associations are summa-
rized in Table 4. There was no evidence for any interaction
between follow-up time and ALM/height2 for any of the fracture
outcomes, incident falls, or mortality, ie, there was no evidence
that the predictive effect of ALM/height2 was different at the
beginning, compared with at the end, of the follow-up period.
Discussion
Consistent with our findings in older men, we have demon-
strated that greater DXA ALM/height2 is modestly predictive of
lower risk of incident fractures but that this association is mark-
edly attenuated by adjustment for femoral neck BMD. Indeed,
there was evidence of inversion of the relationship after BMD
T-score adjustment such that greater ALM/height2 was associ-
ated with greater fracture risk. Interestingly, there was no associ-
ation with incident falls. However, ALM/height2 was associated
positively with risk of death during follow-up in all models.
Table 1. Baseline Characteristics of the Participants
No. with data Mean/n SD/% Range
Age (years) 11,187 63.3 7.4 50–79
Height (cm) 11,187 161.6 6.4 98.5–212.0
BMI (kg/m2) 11,180 28.2 5.9 14.3–69.1
Prior fracture 7685 1325 17%
Parental history of hip fracture 10,927 1326 12%
Current smoking 11,029 889 8%
Corticosteroids 11,187 98 1%
Rheumatoid arthritis 10,384 607 6%
Excess alcohol intake 11,151 324 3%
Femoral neck BMD (g/cm2) 11,187 0.72 0.13 0.3–1.5
FRAX MOF without BMD 11,187 9.8 6.9 0.7–66.9
FRAX MOF with BMD 11,186 10.4 7.7 1.0–79.3
Prior falls 10,067 3307 33%
ALM (g) 11,187 14,769 2809 7742–31,903
ALM/height2 (g/cm2) 11,187 0.56 0.10 0.3–1.7
ALM/height2 – normalized 11,187 0.00 1.00 −3.4–6.7
During follow-up
Length of follow-up 11,187 14.1 5.6 0.0–21.5
Any fracture 11,187 1692 15%
Osteoporotic fracture 11,187 1225 11%
MOF 11,187 1024 9%
Hip fracture 11,187 344 3%
Falls 11,144 7720 69%
Death 11,187 2236 20%
BMI = body mass index; BMD = bone mineral density; FRAX = Fracture Risk Assessment Tool; MOF = major osteoporotic fracture; ALM = appendicular
lean mass.
Table 2. Associations Between DXA ALM/Height2 and Incident Fracture Outcomes
Exposure (SD) Adjustment Any fx Ost fx MOF fx Hip fx




0.88 (0.83, 0.94) p < .001 0.81 (0.71, 0.91)
p < .001




0.89 (0.83, 0.96) p = .0013 0.81 (0.72, 0.92)
p = .0010




0.95 (0.89, 1.02) p = .15 0.86 (0.76, 0.98)
p = .019




0.96 (0.90, 1.03) p = .25 0.88 (0.78, 1.00)
p = .044




1.06 (0.98, 1.14) p = .12 1.00 (0.88, 1.14)
p > .30
DXA = dual-energy X-ray absorptiometry; ALM = appendicular lean mass; fx = fracture; Ost = osteoporotic; MOF = major osteoporotic fracture; FU = fol-
low-up; FRAX = Fracture Risk Assessment Tool; BMD = bone mineral density; FN = femoral neck.
Models are presented adjusted for age and follow-up time alone and then additionally for either prior falls, FRAX MOF probability without BMD, FRAX
MOF probability with BMD, or femoral neck BMD T-score. Associations where p < 0.05 are in bold. Data are gradient of risk (hazard ratio per SD) and 95%
confidence interval.
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Our finding that lower DXA ALM/height2 was modestly pre-
dictive of greater fracture incidence independently of past falls
and FRAX probability appears consistent with our recent obser-
vations among men in MrOS(6) and with previous findings from
the Health ABC study(7) and Framingham study.(9) In all three set-
tings, the ALM-fracture relationship was markedly attenuated by
the addition of femoral neck BMD T-score, whereas greater ALM
(or ALM/height2) appeared to be a risk factor for hip fracture after
accounting for femoral neck BMD. In contrast, in the Swiss GER-
ICO study, adjustment of low leanmass for BMD did not substan-
tially attenuate associations with incident fracture.(16) In an
earlier WHI analysis, participants were classified into mutually
exclusive groups based on BMD and sarcopenia (dichotomous
variable according to appendicular leanmass adjusted for height
and fat mass) status.(8,17) Low BMD was associated with
increased risk of hip fracture, but women with sarcopenia alone
had similar hazard ratios for hip fracture to non-sarcopenic
women with normal BMD, suggesting that sarcopenia alone is
not predictive of hip fracture. In a further WHI study of 872 partic-
ipants 65 years or older whomet Fried’s criteria for frailty, appen-
dicular lean mass was associated with incident hip fracture, but
this association did not remain statistically significant after
adjusting for hip BMD.(18)
There are several potential reasons why DXA appendicular
lean mass might not have optimal predictive capacity for inci-
dent fracture outcomes.(1) ALM represents all the tissue that is
neither fat nor bone and thus includes contributions from
non-muscle connective tissue, skin, and ligaments.(19) The cor-
relation between ALM/height2 and femoral neck BMD in the
present population was 0.41. This is similar to that we observed
in men in the MrOS cohorts(6) and consistent with our under-
standing of the underlying DXA algorithms and biology. Impor-
tantly, ALM and femoral neck BMD are derived from the same
instrument, ie, DXA, and the nature of the algorithms used
effectively means that a mathematical relationship between
lean mass and BMD is inevitable.(19) Finally, it is likely that those
with lower lean mass also have lower bone mass, and there is a
well-established biomechanical relationship between muscle
and bone, as described by the mechanostat hypothesis.(20) This
suggests positive causal adaptations of bone mass to muscle
strain, and indeed, in the MrOS cohort, we observed that mea-
sures of physical performance such as gait speed and chair
stand time, together with grip strength, appeared to be rather
more robust predictors of incident fracture than did DXA
ALM.(6) Other studies have similarly demonstrated the greater
predictive capacity of physical function over this estimate of
muscle mass.(21–25) Importantly, muscle quality and adiposity
cannot be adequately assessed using DXA, and taken as a
whole, these findings suggest that other measures of muscle,
such as creatine dilution(26) or muscle cross-sectional area or
density from (p)QCT,(27,28) might be usefully evaluated as mea-
sures of muscle mass.
Previous studies examining associations between baseline sar-
copenia and incident falls have demonstrated either increased
falls risk(29) or no association with this exposure.(30,31) Indeed in a
study of the predictive value of four sarcopenia definitions for
Fig 1. Associations between DXA appendicular leanmass (ALM)/height2 (SD) and incident fracture outcomes. Models are presented adjusted for age and
follow-up time alone and then additionally for either prior falls, Fracture Risk Assessment Tool (FRAX) major osteoporotic fracture (MOF) probability with-
out bone mineral density (BMD), FRAX MOF probability with BMD, or femoral neck BMD T-score. Data are gradient of risk (hazard ratio per SD) and 95%
confidence interval.
Table 3. Associations Between DXA ALM/height2 and Incident
Falls and Death
Exposure
(SD) Adjustment Falls Death
ALM/
height2




















DXA = dual-energy X-ray absorptiometry; ALM = appendicular lean
mass; FU = follow-up; FRAX = Fracture Risk Assessment Tool; BMD= bone
mineral density; FN = femoral neck.
Models are presented adjusted for age and follow-up time alone and
then additionally for either prior falls, FRAX MOF probability without
BMD, FRAX MOF probability with BMD, or femoral neck BMD T-score.
Associations where p < 0.05 are in bold. Data are gradient of risk (hazard
ratio per SD) and 95% confidence interval.
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falls-related hospitalization in older Australian women, there was
no association for sarcopenia definitions overall. In contrast the
component measures of muscle strength and physical function,
but not DXA ALM, were associated with falls risk.(31) Few previous
investigations have focused on appendicular lean mass. However,
our finding of a lack of association between ALM/height2 and inci-
dent falls is consistent with recent results from MrOS, in which,
whereas measures of skeletal muscle using creatine dilution were
associated with injurious falls, there was little evidence of any pre-
dictive value for DXA ALM.(26)
Our finding of a positive association between ALM/height2
and incident mortality is possibly somewhat counterintuitive
and contrasts with results from the Tasmanian Older Adult
Cohort. Here, among 1041 women, mean age 63 years, low
ALM/height2 was not associated with increased mortality,
although the point estimate was in the opposite direction
(low ALM, greater mortality) to that which we observed in our
present analysis. Furthermore, low ALM divided by BMI was sta-
tistically significantly associated with greater mortality.(30) In
contrast, in our analysis, use of ALM/BMI yielded no evidence
of association (data not shown). Our finding is consistent with
associations demonstrated previously in WHI, between greater
percentage lean body mass (ie, not absolute ALM) and
increased mortality. However, this association was only
observed in women aged 70 to 79 years, whereas the opposite
association of lower risk of death with greater percentage lean
body mass was observed in women 50 to 59 areas old.(32) Con-
versely, in our analysis, we observed a tendency for the adverse
relationship between ALM and mortality to be of greater mag-
nitude at younger ages. Our greater ALM–greater mortality
finding was consistent regardless of incorporation of ALM
alone or ALM/height2 in the models, and robust to adjustment
for fat mass or waist-hip ratio. However, it is not altogether pos-
sible to fully account for an effect of fat mass, given the collin-
earity between fat and lean in both DXA measurement and
biological terms; while more detailed understanding of these
findings awaits investigation in other cohorts, these findings
indicate the complexity of relationships between bone health,
body composition, and functional measures as predictors of
future outcomes.
We studied a very large, uniformly characterized cohort of
older women. The exposure and outcomes were validated,
and we were able to account for other potential confounding
factors. However, there are some limitations that should be
considered in the interpretation of our findings. First, the
cohort consisted solely of older women, limiting generalizabil-
ity. However, we undertook this analysis to evaluate whether
our previous findings in older men also applied to older
women. Second, we were not able to investigate other
measures of muscle mass to evaluate their performance char-
acteristics in comparison with DXA ALM lean mass. Third, sec-
ondary causes of osteoporosis were rare in this population
and were difficult to align with FRAX definitions, and so this
specific input variable was set to zero in the FRAX models. This
is likely to have slightly reduced the overall FRAX probabilities
but is unlikely to have influenced the relationships observed.
Indeed, selection of secondary causes as an input variable in
the FRAX model does not contribute to the output fracture
probability when BMD is included in the FRAX calculation, since
the core assumption is that these conditions contribute via
BMD.(33) Fourth, WHI has a complex structure comprising an
observational cohort and trials of calcium and vitamin D versus
placebo and hormone therapy versus placebo. Although we
adjusted for randomization, it remains possible that there
might be some residual effect of the interventions. Fifth, differ-
ent DXA instruments were used in different centers over time,
and it was not possible to scan participants above the manufac-
turer’s weight limit for the instrument. Cross-calibration was
undertaken, but it is possible that these considerations might
have attenuated the magnitude of associations we observed.
Finally, we had limited ability to delineate underlying mecha-
nisms in this study design. However, our primary objective
was to elucidate risk relationships that would be useful in risk
assessment. In this context, causality and mechanism are
second-order considerations, that is, for a risk factor to be use-
ful in risk prediction, it is sufficient that it be associated with the
outcome, regardless of whether the relationship is causal. Thus,
although we did undertake post hoc exploratory analyses in an
attempt to shed further light on the unexpected positive asso-
ciation between ALM/height2 and mortality, we did not there-
fore undertake such mechanistic analyses more widely.
In conclusion, we have confirmed in older women our recent
finding in older men, that DXA appendicular lean mass is only
modestly predictive of incident fracture outcomes and does
not add fracture risk information over and above femoral neck
BMD and FRAX probability. In contrast, greater ALM/height2
was associated with a modestly greater hazard of death during
the follow-up. Our findings suggest that the inclusion of DXA
ALM in sarcopenia definitions contributes minimal predictive
information for falls and fracture, supporting the approach
taken in the most recent US(4,5) and European(3) sarcopenia
definitions.
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Table 4. Associations between DXA ALM/height2 and Incident Outcomes at Specific Ages
Age (years) Ost fx Hip fx Falls Death
All 0.90 (0.85, 0.96) 0.81 (0.71, 0.91) 0.98 (0.96, 1.01) 1.13 (1.08, 1.18)
50 0.91 (0.77, 1.08) 0.60 (0.39, 0.91) 1.03 (0.97, 1.08) 1.32 (1.13, 1.54)
60 0.91 (0.82, 1.00) 0.67 (0.50, 0.88) 1.00 (0.97, 1.03) 1.25 (1.12, 1.38)
70 0.90 (0.84, 0.96) 0.75 (0.64, 0.87) 0.97 (0.95, 0.99) 1.18 (1.10, 1.25)
80 0.90 (0.81, 0.99) 0.84 (0.74, 0.95) 0.95 (0.91, 0.99) 1.11 (1.05, 1.17)
p-value interaction ALM/height2 x age on outcome >0.30 0.15 0.092 0.035
DXA = dual-energy X-ray absorptiometry; ALM = appendicular lean mass; Ost = osteoporotic; fx = fracture.
Models are adjusted for age and follow-up time alone. Associations where p < 0.05 are in bold. Data are gradient of risk (GR; hazard ratio per SD) and 95%
confidence interval. Note that GR is calculated at each specific age from hazard functions.
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